PARTICIPANTS NOT ON THE HODGKIN LYMPHOMA EXPANSION COHORT: Creatinine < 1.5 UNL or creatinine clearance (CrCl) > 50 ml/min, within 2 weeks prior to enrollment
Serum creatinine =< 1.2 x ULN or creatinine clearance >= 60 mL/min; obtained within 14 days prior to study entry
Re-registration: creatinine =< 1.5 ULN OR calc. creatinine clearance > 45 mL/min (using lean body mass formula only)
Serum creatinine =< 1.5 x upper limit of normal (ULN) or serum creatinine clearance (CrCl) >= 40 ml/min, obtained within 4 weeks prior to randomization
Patients must have creatinine clearance =< 2.5 x IULN
Creatinine clearance >= 45 ml/min documented within 28 days prior to step 1 registration
Calculated (calc.) creatinine clearance >= 50 mL/min\r\n* Estimated creatinine clearance for patients >= 18 years old will be estimated by the Jelliffe equation modified for body surface area (BSA); patients with creatinine clearance estimated > 70ml/min by this formula are eligible; if the creatinine clearance estimated by the Jelliffe method is >= 50 mL/min but =< 70 mL/min, then a second method to confirm a creatinine clearance of >= 50 mL/min is required; methods of estimating glomerular filtration rate (GFR) that can be used for this confirmation consist of a 12 or 24-hour urine creatinine clearance or a nuclear creatinine clearance test; if the confirmatory creatinine clearance is < 50 mL/min, then the patient is not eligible; if the confirmatory creatinine clearance is >= 50 mL/min, the patient is eligible; if the cause of the patient’s renal dysfunction is tumor obstructing the ureters, then eligibility can be determined by the study chair even if it does not meet these minimal requirements; for patients < 18 years old, it is strongly suggested that a radioisotope estimation of GFR be obtained; if a radioisotope test is not possible, an estimated creatinine clearance using either a 12 or 24 hour urine creatinine clearance or the Schwartz formula can be used; patients will be considered eligible if the creatinine clearance is > 70 mL/min; if the creatinine clearance estimated by the Schwartz formula or urine creatinine clearance is >= 50 mL/min but =< 70 mL/min, then a second method to confirm a creatinine clearance of >= 50 mL/min is required; methods of estimating GFR that can be used for this confirmation consist of a 12- or 24-hour urine creatinine clearance if the Schwartz formula or radioisotope method was used as the primary method or a radioisotope estimation of GFR if the Schwartz formula or urine creatinine clearance method was used as the primary method; if the confirmatory creatinine clearance is < 50 mL/min, then the patient is not eligible; if the confirmatory creatinine clearance is >= 50 mL/min, the patient is eligible
Creatinine =< 1.5 mg/dL OR creatinine clearance >= 45mL/min
Serum creatinine clearance >= 30 ml/min
Obtained within 14 days prior to treatment start: Serum creatinine (CREAT) =< 1.5 mg/dL or creatinine clearance >= 50 mL/min
creatinine clearance ?60 mL/min/1.73 m2 for subjects with serum creatinine levels >1.5 × higher than ULN.
Creatinine < 1.4 mg/dl and/or a measured creatinine clearance > 60 cc/min
Serum creatinine =< 1.5 mg/dL; if serum creatinine is > 1.5 mg/dL, calculate creatinine clearance using standard Cockcroft-Gault formula; creatinine clearance must be >= 50 mL/min to be eligible
Creatinine clearance >= 30 mL/min
ELIGIBILITY CRITERIA - PHASE I (ARMS A, B, C): Creatinine clearance of at least 50 mL/min within 7 days prior to first dose of study agent
ELIGIBILITY CRITERIA - PHASE II (ARM D): Creatinine clearance of at least 50 mL/min within 7 days prior to first dose of study agent
Serum creatinine ? 1.5 × upper limit of normal (ULN) or creatinine clearance (CrCl) ? 40 mL/min/1.73 m2
Creatinine > 1.5 times ULN concurrent with creatinine clearance < 50 ml/min; confirmation of creatinine clearance is only required when creatinine is > 1.5 times ULN
Creatinine clearance (CrCl) >= 60 mL/min
Serum creatinine > 1.5 x ULN and/or creatinine clearance ? 50 mL/min
Creatinine clearance < 40 mL/min
Creatinine clearance > 50mL/min
Serum creatinine =< 1.5 mg/dL or creatinine clearance >= 50 mL/min
Serum creatinine =< 1.5 mg/dL or estimated creatinine clearance >= 50 ml/min
Serum creatinine < 140 ?mol/L (< 1.6 mg/dL) or creatinine clearance > 60 mL/min.
Chemistry Total bilirubin ? 2 mg/dL AST and/or ALT > 3 x ULN Serum creatinine > 1.5 x ULN and/or creatinine clearance ? 45 mL/min
Creatinine =< 1.5 x upper limit of normal OR creatinine clearance >= 50 mL/min
Serum creatinine =< 1.5 x institutional ULN or 24-hour clearance >= 50 mL/min
Creatinine clearance =< 50 mL/min
Serum creatinine =< 1.5 mg/dL OR creatinine clearance >= 50 mL/min/1.73 m^2
CrCl ? 50 mL/min
Serum creatinine =< 1.5x ULN for age OR a creatinine clearance or radioisotope GFR >= 70ml/min/1.73 m^2
Creatinine =< 1.5 x ULN or creatinine clearance > 60 ml/min
Creatinine clearance ? 40 mL/min (see Section 7.2.1 for instructions regarding calculation of creatinine clearance) performed within 28 days prior to randomization.
Creatinine clearance (CrCl) =< 40 mL/min
Adequate renal function assessed by serum creatinine within reference lab normal limits and creatinine clearance (by Chronic Kidney Disease Epidemiology [CKD-EPI] Collaboration equation) ?60 mL/min.
Obtained =< 21 days prior to registration: creatinine =< 2 mg/dL or creatinine clearance >= 40 mL/min
Serum creatinine < 1.5 x upper limit of normal (ULN) or 24-hour creatinine clearance > 50 ml/min
Creatinine =< 1.5 x IULN OR creatinine clearance >= 40 mL/min/1.73 m^2 for patients with creatinine levels > 1.5 x IULN (that is, if serum creatinine is > 1.5 x IULN, a 24-hour urine collection to calculate creatinine clearance must be performed)
Serum creatinine < 1.5 mg/dL or creatinine clearance >= 50 mL/min
Obtained =< 2 weeks prior to registration: Creatinine clearance >= 50 mL/min
Serum creatinine < 2.0 x ULN or creatinine clearance > 30 cc/min performed within 30 days prior to the date of registration
Serum creatinine > 1.5 mg/dL. If serum creatinine > 1.5 mg/dL, the measured creatinine clearance must be measured and patient is eligible if creatinine clearance > 45 mL/min.
Serum creatinine < 1.5 mg/dL or creatinine clearance >= 50 mL/min
CrCl (Creatinine Clearance) is >= 15 ml/min (<= 7 days prior to enrollment)
Creatinine clearance >= 60 mL/min/1.73 m^2
Within 28 days of study registration: Normal serum creatinine or creatinine clearance >= 60 ml/min/1.73 m^2
Creatinine clearance ? 50 mL/min
Obtained =< 35 days prior to registration: creatinine =< 1.5 mg/dL or creatinine clearance >= 50 mL/min
Serum creatinine < 2.0 mg/dL or creatinine clearance >= 50 mL/minute
Creatinine clearance greater than or equal to (>=) 30 milliliters per minute (mL/min)
Serum creatinine ? 1.5 X ULN (OR creatinine clearance ? 60 mL/min/1.73 m2)
Serum creatinine =< 1.5 x institution’s ULN, or creatinine clearance >= 30 ml/min
Creatinine >1.5 times ULN concurrent with creatinine clearance <50 mL/min
Serum creatinine > 1.5 x OR creatinine clearance of at least 40
Serum creatinine clearance >= 15 mL/min (performed within 14 days of treatment initiation)
Patient may not have severe renal disease (creatinine greater than 3 times normal for age OR creatinine clearance < 50 ml/m^2/1.73 m^2)
Creatinine clearance >= 60 mL/min/1.73 m^2
Adequate organ function within 14 days of study registration including:\r\n* Normal serum creatinine or creatinine clearance >= 60 ml/min/1.73 m^2
Estimated creatinine clearance >= 45 ml/min
Either an estimated creatinine clearance value of > 50 mL/min as determined by the Chronic Kidney Disease Epidemiology (CKD EPI) or MDRD (Modification of Diet in Renal Disease) formulae or a creatinine clearance value of > 50 mL/min based on a 24 hour urine collection
Serum creatinine =< 2.0 x institution’s ULN or 24-hour creatinine clearance >= 50 ml/min
Creatinine within 2 times normal institutional limits OR creatinine clearance >= 30 mL/min/1.73 m^2; Note, dose adjustments are required for creatinine clearance (CrCl) >= 30 mL/min but =< 60 ml/min
Creatinine clearance ?60 mL/min
Creatinine ? 1.5 x ULN or creatinine clearance (CrCl) ? 60 mL/min
Serum creatinine >1.5 x ULN and/or measured creatinine clearance < 40 ml/min
Adequate renal function as demonstrated by serum creatinine ? 1.5 x ULN or 24-hour urine creatinine clearance calculation ? 60 mL/min.
Estimated creatinine clearance > 30 cc/min within four weeks of enrollment
Serum creatinine <= 1.5 mg/dL. (or estimated creatinine clearance >= 50 ml/min/1.73 m2)
Serum creatinine =< 1.5 mg/dL or estimated creatinine clearance >= 60 ml/min using Crockcroft-Gault estimation
Serum creatinine =< 2 x upper limit of reference range or creatinine clearance >= 30 ml/min
Creatinine =< 1.5 or creatinine clearance >= 60 ml/ml
Creatinine < 2.0 mg/dL (for adults) or creatinine clearance > 60 ml/min (for children)
Serum creatinine =< 2.0 mg/dL or creatinine clearance of > 40 ml/min within 45 days prior to initiation of therapy. (Patients with documented marrow involvement (with lymphoma) or hypersplenism secondary to involvement of the spleen by lymphoma at the time of randomization are not required to meet the parameter).
Creatinine clearance >= 40 mL/min
Serum creatinine =< 1.5 mg/dL or creatinine clearance >= 50 mL/min
Estimated creatinine clearance must be > 40 mL/min
Serum creatinine ?1.5x the ULN or creatinine clearance (CrCl) ?50 mL/min.
Creatinine clearance < 20 ml/min
A pretreatment measured creatinine clearance (absolute value) of >= 60 ml/minute
Creatinine clearance (CrCl) < 30 ml/min/1.73m^2. Creatinine clearance is estimated by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula
Creatinine clearance > 30 mL/min
Serum creatinine =< 1.5 x ULN or 24-hour creatinine clearance >= 50 ml/min
Creatinine clearance >= 30 mL/min
Serum creatinine < 2.0 mg/dL OR creatinine clearance (Cockcroft) >= 40 mL/min/1.73 m^2
Creatinine clearance >= 15 ml/min
Creatinine less than 1. 5 X ULN and/or creatinine clearance >= 60 mL/min
Measured creatinine clearance >45 mL/minute (as assessed with a 24-hour urine collection)
Obtained within 21 days prior to cycle 1, day 1: serum creatinine clearance >= 50ml/min
Creatinine: Creatinine clearance > 25 ml/min
Serum Creatinine or Creatinine Clearance** ? 1.5 x ULN, > 50 mL/min
COHORT 1: HORMONE RECEPTOR POSITIVE BREAST CANCER: Serum creatinine =< 1.5 X upper limit of normal (ULN), or measured creatinine clearance >= 60 mL/min/1
COHORT 2: TRIPLE NEGATIVE BREAST CANCER: Serum creatinine =< 1.5 X upper limit of normal (ULN), or measured creatinine clearance >= 60 mL/min/1
COHORT 3: ENDOMETRIAL CANCER: Serum creatinine =< 1.5 X upper limit of normal (ULN), or measured creatinine clearance >= 60 mL/min/1
Creatinine clearance 30-75 mL/min
Creatinine clearance ? 50 mL/min
Creatinine clearance > 50 ml/min
Creatinine clearance >= 50 mL/min
Creatinine clearance ? 45ml/min
Creatinine =< 1.5 mg/dL OR creatinine clearance >= 45 mL/min
Creatinine clearance of >= 50 mL/min
Creatinine clearance >= 50 cc/min
Creatinine clearance < 30 ml/min
Creatinine clearance >= 30 ml/min
Within 3 days before the first dose of study drug: creatinine clearance > 50 mL/min
Serum creatinine (Cr) =< 1.5 X ULN or creatinine clearance (CrCl) >= 50 ml/min
Either creatinine > 2.0 mg/dL or creatinine clearance < 30 mL/min
Serum creatinine =< 2.0 mg/dl and/or creatinine clearance of > 40 ml/min (excludes multiple myeloma patients receiving high dose melphalan conditioning)
Serum creatinine =< 2 mg/dL OR creatinine clearance > 50 mL/min.
Creatinine clearance >= 50 mL/min.
Serum creatinine =< 1.5 mg/dL OR creatinine clearance >= 50 mL/min/1.73 m^2.
Serum creatinine < 2.5 mg/dL or creatinine clearance > 30 cc/min
Subjects with severe renal impairment (i.e., creatinine clearance =< 30 mL/min)
Serum creatinine clearance or radioisotope GFR ?50 milliliters/minute/1.73 m^2, based on a 12 or 24 hours (h) urine creatinine collection.
Creatinine clearance >= 40 mL/min/1.73 m^2
Creatinine clearance >= 60 mL/min/1.73 m^2
Serum creatinine =< 2.0 mg/dL OR creatinine clearance >= 60 mL/min/1.73 m^2 for patients with creatinine levels above 2 mg/dL (unless dysfunction is secondary to lymphoma involvement); creatinine clearance (Cr Cl) will be calculated with the use of the 24-hour creatinine clearance or modified Cockcroft-Gault equation
Within 14 days of the first dose of study drug: Serum creatinine =< 1.5 times the upper limit of normal or estimated creatinine clearance (CrCL) > 40 mL/min
For Arm G, subjects must have an estimated creatinine clearance >= 50 ml/min.
Serum creatinine =< 2.0 mg/dL OR creatinine clearance >= 50 mL/min/1.73 m^2, at the time of enrollment
Serum creatinine clearance >= 30 mL/min
Creatinine levels < 2 mg/dL; or creatinine clearance > 40 mL/min
Creatinine clearance >= 60 mL/min/1.73 m^2 unless reduced creatinine clearance felt by investigator to be acute and reversible
Serum creatinine less than or equal to 1.5 mg/dl unless the measured creatinine clearance is greater than 60 mL/min/1.73 m^2
Measured creatinine clearance > 60 mls/min
Creatinine clearance < 30 ml/min
Creatinine clearance >= 50 ml/min
Serum creatinine clearance >= 30 mL/min
Renal: Serum creatinine 1.5 x ULN or creatinine clearance 60 mL/min.
Creatinine =< 2.0 mg/100 ml
Serum creatinine =< 1.5 x institution’s upper limit of normal (ULN), or creatinine clearance >= 60 ml/min
Creatinine clearance ? 50 ml/min
Serum creatinine =< 1.5 mg/dL or 24-hour clearance >= 50 mL/min
Creatinine =< 1.5 x ULN OR creatinine clearance >= 50 mL/min/1.73 m^2
Docetaxel: Creatinine clearance no minimum
Cabazitaxel: Creatinine clearance >= 30 mL/min/1.73 m^2
Creatinine clearance of >= 60 ml/min
Creatinine clearance >= 15 mL/min
Serum creatinine =< 2.0 mg/dl or creatinine clearance > 60 ml/min within 30 days of enrollment to study
Serum creatinine =< 1.8 mg/dL or creatinine clearance > 50 mL/min
Estimated creatinine clearance >=60mL/min/1.73 square meter (m^2)
Serum creatinine ? 2.0 x ULN or calculated creatinine clearance ? 45 mL/min based on the Cockroft-Gault GFR estimation. For newly diagnosed AML patients < 75 years of age, creatinine clearance ? 30 mL/min; for ? 75 years of age, creatinine clearance ? 45 mL/min.
Serum creatinine =< 1.5 mg/dL, or if creatinine > 1.5 mg/dL, calculated creatinine clearance of >= 50 mL/min by 24 hour creatinine clearance or Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)
Adequate renal function, as defined by estimated serum creatinine clearance >= 60 ml/min and a normal serum creatinine for age
Obtained =< 7 days prior to registration: Serum creatinine =< 2 x ULN or 24 hour creatinine (Cr) clearance > 60 ml/min
Creatinine =< 2.0 mg/dL (adults) and creatinine clearance > 40 mL/min (pediatrics); adults with a creatinine > 1.2 or a history of renal dysfunction must have estimated creatinine clearance > 40 ml/min/1.73m^2
Serum creatinine =< 1.5 x ULN or creatinine clearance (CrCl) >= 40 mL/min
Estimated creatinine clearance > 45 ml/min
Serum creatinine =< 1.5 x institutional ULN or 24-hour clearance >= 50 mL/min
Serum creatinine =< 1.5 x ULN, or 24-hr clearance >= 60 ml/min, within 14 days start of study start
Serum creatinine =< 1.5 X upper limit of normal (ULN), or measured creatinine clearance >= 60 mL/min/1.73 m^2
Estimated creatinine clearance > 40 mL/min (this must be checked twice before initiating therapy)
Serum creatinine <1.5 mg/dl or creatinine clearance?50 mL/min
Creatinine clearance < 30 mL/min
Serum creatinine > 1.5 x ULN for age or creatinine clearance =< 60 mL/min/1.73 m^2
Creatinine clearance > 25 ml/min
Patients must have creatinine of less than or equal to 1.5 mg/dL or creatinine clearance > 60 ml/min
Estimated or measured creatinine clearance > 50 mL/min
Serum creatinine =< 1.5 mg/dL or creatinine clearance >= 60 mL/min
Creatinine clearance (CrCl) must be > 20 mL/min
Creatinine clearance greater than 30 ml/min
Serum creatinine clearance >= 30 ml/min
Creatinine clearance >= 40 ml/min or serum creatinine =< 2.5 x upper limit of normal (ULN)
Creatinine =< 2.0 mg/dl (adults) and creatinine clearance >= 40 mL/min (pediatrics); adults with a creatinine > 1.2 mg/dl or a history of renal dysfunction must have estimated creatinine clearance >= 40 ml/min/1.73m^2
Adequate kidney function with serum creatinine <2 x the ULN or creatinine clearance >30 mL/min
Serum creatinine ? 1.5 x ULN or estimated creatinine clearance ? 60 mL/min
Creatinine clearance >= to 50 ml/min
Serum creatinine =< 2 x ULN or 24 hour creatinine (Cr) clearance > 30 ml/min obtained =< 7 days prior to registration
Adequate renal function as demonstrated by a serum creatinine ?1.5 mg/dL or a creatinine clearance >60 mL/min;
Creatinine =< 1.5 x the upper limit of normal (ULN) OR \r\n* Estimated creatinine clearance of > 50 ml/min\r\n* Patients with renal dysfunction deemed to be the result of disease will be considered eligible
Serum creatinine less than or equal to 1.3 mg/dL and/or creatinine clearance > 40 mL/min
Creatinine clearance (CrCl) value of >= 60 ml/min by MDRD study equation
Serum creatinine =< 1.5 X ULN (OR creatinine clearance >= 60 mL/min/1.73 m^2)
Serum creatinine =< 1.5 mg/dL or creatinine clearance >= 50 mL/min
Estimated serum creatinine clearance >= 50 ml/min (Modification of Diet in Renal Disease [MDRD] method) and/or serum creatinine =< 1.8 mg/dL
Creatinine clearance < 30 ml/min which cannot be attributed to MCC metastasis
Serum creatinine =< 1.5 x ULN or creatinine clearance (CrCl) >= 40 mL/min
Creatinine clearance of >= 60 mL/min
Estimated creatinine clearance less than 50 ml/minute
Serum creatinine =< 2.5 or estimated creatinine clearance >= 30 ml/min and not dialysis-dependent
Creatinine clearance (measured via 24-hour urine collection) >= 40 mL/minute (that is, if serum creatinine is > 1.5 times the ULN, a 24-hour urine collection to calculate creatinine clearance must be performed
Serum creatinine =< 1.8 mg/dL and/or estimated serum creatinine clearance >= 50 ml/min
Creatinine =< 1.5 mg/dL or creatinine clearance >= 60 ml/min
Renal: Serum/plasma creatinine (sCr) ?1.5 x upper limit of normal, or creatinine clearance (Ccr) ?50 mL/min.
Creatinine clearance >= 30 ml/minute
A pretreatment measured creatinine clearance (absolute value) of >= 50 ml/minute
Creatinine (Cr) clearance >= 30 mL/min
Creatinine clearance >= 45 mL/min
Creatinine > 2 mg/dL and an estimated creatinine clearance =< 40 mL/min
Estimated creatinine clearance must be > 40 mL/min
Creatinine clearance of < 50 ml/min
Estimated creatinine clearance < 15 mL/min
Serum creatinine =< 1.5 X upper limit of normal OR creatinine clearance on a 24-hour (h) urine collection of >= 60 mL/min
Serum creatinine =< 1.5 mg/dL, or if serum creatinine is > 1.5 mg/dL, creatinine clearance must be >= 50 mL/min (calculate creatinine clearance using the Cockcroft-Gault formula
Creatinine less than 1.5 x ULN, or a 24 hour creatinine clearance of 60 mg/mL or more
Creatinine clearance or radioisotope GFR ? 70ml/min/1.73 m² OR age/gender appropriate serum creatinine.
Serum creatinine of < 1.5 mg/dL, and a measured creatinine clearance of > 60 mL/min
Creatinine clearance >= 30 mL/minutes
Serum creatinine =<1.5 mg/dL or creatinine clearance > 50 ml/min; some patients with minor deviations may be accepted on protocol after discussion with the PI
Creatinine clearance of >= 50
24-hour urine creatinine clearance >= 50 mL/min, obtained within 30 days of study registration
Serum creatinine < 1.5 mg/dl or creatinine clearance (CrCl) > 60 mL/min, performed within 28 days prior to registration
Serum creatinine =< 1.5 times the upper limit of normal or estimated creatinine clearance (CrCl) > 40 mL/min within 14 days of the first dose of study drug
Creatinine clearance (Clcr) > 25 mL/min
Creatinine clearance < 30 ml/min
Renal insufficiency, with creatinine greater than 1.5 mg/mL
Estimated creatinine clearance >= 50 mL/min
Within 30 days of first vaccination: Serum creatinine =< 1.2 mg/dl or creatinine clearance > 60 ml/min
Creatinine clearance >= 30 mL/min/1.73 m^2
Creatinine clearance < 50 mL/min/1.73m^2
Serum creatinine =< 1.5 x ULN or 24-hour clearance >= 50 mL/min
Serum creatinine =< 1.5 mg/dL or a measured creatinine clearance >= 50 mL/min (to be performed within 7 days prior to start of study treatment)
Serum creatinine =< 1.5 mg/dL OR creatinine clearance >= 50 mL/min/1.73 m^2
Measured creatinine clearance >= 40 ml/min per 24 hour urine collection OR serum creatinine =< 1.3 mg/dL
Serum creatinine =< 1.5 x ULN or 24-hour clearance >= 50 ml/min
Estimated creatinine clearance at least 50 ml/min
Serum creatinine < 1.5 times upper limit of normal range (ULN) or creatinine clearance >= 40 ml/min
Creatinine clearance > 50 ml/min/1.73 m^2 (Schwartz formula)
Serum creatinine within normal range with a creatinine clearance >= 30 ml/min
Serum creatinine =< 1.5 x upper limit of normal OR creatinine clearance on a 24-h urine collection of >= 60 mL/min
Relapsed/refractory MCL: Creatinine (Cr) clearance >= 30 mL/min
Newly diagnosed MCL: Creatinine (Cr) Clearance >= 30 mL/min
RECIPIENT: Creatinine: adult patients: =< 2.0 mg/dl and creatinine clearance >= 30 ml/min; pediatric patients (< 18 years old) creatinine < 1.5 mg/dL and a creatinine clearance > 30 mL/min/1.73 m^2
Serum creatinine =< 1.5 x ULN or 24-hour clearance >= 50 ml/min
Creatinine clearance (CrCl) > 45 mL/min
Creatinine clearance >= 50 ml/min/1.73m^2
Severe renal insufficiency (estimated creatinine clearance <20 mL/min) or on hemodialysis at the time of randomization or likely to require dialysis during the study.
Creatinine clearance of >= 60 mL/min
Serum creatinine < 1.5 mg/dL or creatinine clearance greater or equal than 60 cc/min as defined by the Cockcroft-Gault Equation: Males(mL/min):(140-age)*IBW(kg) / 72*(serum creatinine (mg/dl)); Females (mL/min):0.85*(140-age)*IBW(kg) / 72*(serum creatinine (mg/dl)).
Creatinine clearance equal to or more than 50 mL/min
Serum creatinine < 1.5 mg/dL OR creatinine clearance > 60 mL/min
Creatinine serum =< 2.0 mg/dl or creatinine clearance >= 45 mL/min\r\n* If calculated creatinine clearance is < 45 mL/min, a 24-hour urine collection for creatinine clearance may be performed
Serum creatinine =< 1.5 X upper limit of normal (ULN) or creatinine clearance > 50 mL/min
Serum creatinine =< 2.0 mg/dl or creatinine clearance >= 60 mL/min
Estimated or measured creatinine clearance >= 45 mL/minute
Serum creatinine of =< 1.5 mg/dL, and a measured creatinine clearance of >= 60 mL/min
Patients must have a serum creatinine clearance >= 40 mL/min (as per the Jelliffe method) or by 12-hour or 24-hour urine creatinine clearance
Creatinine < 1.7mg/dL or creatinine clearance >= 60 cc/min (performed within 14 days prior to registration)
Patients must have a platelet count > 100,000/µL, hemoglobin ? 10.0 gm/dL, white blood cell count (WBC) > 2,000/uL, absolute neutrophil count (ANC) ? 1.5 x 109/L, and a serum creatinine ? 1.5 mg/dL unless the measured creatinine clearance is > 40 mL/min/1.73 m2.
Creatinine =< 1.5 mg/dL or creatinine clearance >= 40 mL/min\r\n* If serum creatinine is > 1.5 times the upper limit of normal (ULN), a 24-hour urine collection to calculate creatinine clearance must be performed
Creatinine clearance of >= 60 mL/min
Creatinine must also be < 1.8 mg/dl or a creatinine clearance > 50 ml/min
Creatinine clearance of >= 60 ml/min
Creatinine clearance > 60 ml/min
Creatinine: \r\n* Patients: =< 2.0 mg/dl or creatinine clearance >= 30 ml/min/1.73 m^2\r\n* Pediatric patients (< 18 years old): creatinine =< 1.5 mg/dl or a creatinine clearance of >= 30 mL/min/1.73 m^2
Patients with renal insufficiency or creatinine (cr) clearance < 60 ml/min
Creatinine =< 1.5 or creatinine clearance >= 60 ml/min
Estimated serum creatinine clearance >= 50 ml/min and/or serum creatinine =< 1.8 mg/dL
Estimated creatinine clearance >= 50 ml/min
Serum creatinine =< 2 x the institutional ULN and measured or estimated creatinine clearance > 60 cc/min
Adequate renal function defined as creatinine =< 2.0 mg/dl (adults) or estimated creatinine clearance > 40 ml/min (pediatrics); all adults with a creatinine > 1.2 or a history of renal dysfunction must have estimated creatinine clearance > 40 ml/min
Adequate renal function defined as creatinine =< 2.0 mg/dl (adults) or creatinine clearance > 40 ml/min (pediatrics)
All adults with a creatinine > 1.2 or a history of renal dysfunction must have estimated creatinine clearance > 40 ml/min
Per MDACC Creatinine clearance guidelines, patients must have a Creatinine clearance > 50 ml/min determined by 24 hour collection or nomogram: CrCl male = (140 - age) x (wt in kg)/serum Cr x 72 CrCl female = 0.85 x (CrCl male)
Creatine clearance >= 40 ml/min
Creatinine =< 2.0 mg/100 ml
Creatinine =< 2.0 mg/dl or creatinine clearance > 50 ml/min
Creatinine =< 2.0 mg/dl or creatinine clearance > 50 ml/min
Creatinine < 2.0 (adults) or creatinine clearance > 40 ml/min (pediatrics)
Renal: creatinine =< 2.0 mg/dl (adults) and creatinine clearance > 40 ml/min (pediatrics); adults with a creatinine > 1.2 or a history of renal dysfunction must have estimated creatinine clearance > 40 ml/min
Creatinine =< 1.5 mg/dl or creatinine clearance >= 50 ml/min
Patients with significant renal (creatinine [Cr.] > 1.5 mg/dl or creatinine clearance < 40 cc/min) or hepatic (bilirubin > 2.5 u) dysfunction not due to tumor involvement will not be eligible to receive DA-EPOCH-R chemotherapy
Or creatinine clearance or radioisotope GFR ?50 milliliters per minute (mL/min)/1.73 meters squared (m^2) based on a 12 or 24 hour urine creatinine collection
Creatinine =< 2.0 mg/dl (adults) and creatinine clearance >= 40 mL/min (pediatrics); adults with a creatinine > 1.2 mg/dl or a history of renal dysfunction must have estimated creatinine clearance >= 40 ml/min/1.73 m^2
Creatinine clearance >= 50 mL/min (repeat if more than 3 days before the first dose)
Creatinine >1.5 x ULN, or measured creatinine clearance <60 mL/min, OR 24-hour measured urine creatinine clearance <60 mL/min OR calculated creatinine clearance <60mL/min estimated using the Cockcroft-Gault equation:
Creatinine < (1.5 mg/dL) during screening evaluation (> 1.5 is allowed if EGFR > 45 mL/min/1.73 m^2)
Serum creatinine ? 2 mg/dL and creatinine clearance ? 60 ml/hr
Serum creatinine ? 2 mg/dL and creatinine clearance ? 40 ml/hr
Serum creatinine ? 1.5 x Upper Limit of Normal or creatinine clearance ? 40 mL/min (if using the Cockcroft-Gault formula below): Female Creatinine Clearance = [(140 - age in years) x weight in kg x 0.85] / [72 x serum creatinine in mg/dL] Male Creatinine Clearance = [(140 - age in years) x weight in kg x 1.00] / [72 x serum creatinine in mg/dL]
Creatinine clearance ? 45 cc/min
Serum creatinine > 2.0 mg/dL or creatinine clearance of < 30 mL/min
Serum creatinine =< 1.5 x ULN or 24-hour clearance >= 50 mL/min
Adequate renal function defined by a creatinine clearance of ?30 mL/min
Creatinine clearance ? 30 mL/min
Stable creatinine =< 2.0 mg/dL or creatinine clearance >= 60 ml/min performed within 60 days of enrollment
Creatinine <2.0 mg/dL or creatinine clearance ?50 mL/min
Serum creatinine > 1.5 x upper limit of normal or estimated creatinine clearance (CrCl) < 45 ml/min
Serum creatinine within 1.5 x normal range for age OR creatinine clearance with a recommended eGFR ? 50 mL/min/1.73m^2
Serum creatinine within 1.5 x normal range for age OR creatinine clearance with a recommended eGFR ? 50 mL/min/1.73m^2
Serum creatinine ? 1.5 x ULN, or 24-hour (hr) clearance ? 60 ml/min
Creatinine clearance or radioisotope GFR 70ml/min/1.73 m^2 or
Within 14 days prior to first dose of study drug treatment: Creatinine clearance >= 50 mL/min
Serum creatinine < 1.5 mg/dl or creatinine clearance greater than 60/ ml per minute by the following formula (all tests must be performed within 28 days prior to registration)
Obtained within 28 days prior to registration: Creatinine =< 1.5 mg/dL or creatinine clearance >= 60 mL/min is recommended; however, institutional norms are acceptable
Serum creatinine =< 1.5 × ULN or creatinine clearance >= 50 mL/min/1.73 m^2
Obtained =< 7 days prior to registration: Creatinine =< 2.0 mg/dL or creatinine clearance > 50 mL/min
Creatinine clearance >= 50 mL/min/1.73 m^2
Serum creatinine =< 1.5 x upper limit of normal (ULN) or serum creatinine clearance (CrCl) >= 40 ml/min
Creatinine clearance >= 60 mL/min/1.73 m^2
Serum creatinine < 1.5 x ULN or serum creatinine clearance > 50mL/min
Creatinine =< 1.5 x ULN and concurrent creatinine clearance (CrCl) >= 50 mL/min/1.73 m^2 for patients with creatinine (Cr) > 1.5 x ULN
Creatinine clearance >= 50 mL/min
DOSE ESCALATION COHORT: Serum creatinine ? 1.5 X ULN or creatinine clearance (CrCl) ? 50ml/min
DOSE EXPANSION COHORT: Serum creatinine ? 1.5 X ULN or CrCl ? 50 ml/min
Within 28 days prior to administration of therapy: Creatinine clearance >= 50 mL/min
Patients must have a serum creatinine limit of =< 1.5 ULN or creatinine clearance of >= 60 ml/min measured within 14 days of registration
Creatinine clearance < 50 ml/min
Creatinine < 1.5 mg/dl or creatinine clearance > 60 cc/min
Serum creatinine =< 1.5 mg/dL or creatinine clearance >= 40 ml/min/1.73 m^2 unless lymphoma related
Serum creatinine less than or equal to 1.6 mg/ml or the creatinine clearance must be greater than 70 ml/min/1.73 m^2
Creatinine =< 2.0 mg/dl (adults) or creatinine clearance > 40 ml/min. ); all adults with a creatinine > 1.2 or a history of renal dysfunction must have creatinine clearance (must be > 40 ml/min)
Serum creatinine =< 1.5 × ULN or creatinine clearance >= 50 mL/min
Serum creatinine =< 1.5 mg/dL OR calculated creatinine clearance (Cockroft-Gault formula) >= 30 mL/min OR 24-hour urine creatinine clearance >= 30 mL/min
Blood creatinine =< 1.5 mg/dL (if blood creatinine is > 1.5 mg/dL, calculate creatinine clearance using standard Cockcroft and Gault method or using a 24 hour urine collection for creatinine; creatinine clearance must be > 50 mL/min), within 2 weeks of the first dose of study treatment
Creatinine clearance >= 40 mL/min/1.73 m^2
A pretreatment measured creatinine clearance (absolute value) of >= 60 mL/minute
Creatinine < 2.0 mg/dL or creatinine clearance (CrCl) >= 60 mL/min
Serum creatinine =< 1.5 x upper limit of normal OR creatinine clearance on a 24-h urine collection of >= 60 mL/min
Serum creatinine less than or equal to 1.5 mg/dl unless the measured creatinine clearance is greater than 60 mL/min/1.73 m^2
Serum creatinine =< 2.0 x upper limit of normal (ULN) or serum creatinine clearance (CrCl) >= 40 ml/min
Patient with severe renal disease (i.e. creatinine greater than 3 times normal for age; creatinine clearance less than 50 ml/min/1.73m^2)
Creatinine clearance > 30 cc/min
Creatinine ? 2 mg/dL OR creatinine clearance ? 50 mL/min
Creatinine < 2.0 mg/dL OR creatinine clearance > 60 mL/min/1.73 m^2
Creatinine =< 1.5 times ULN OR measured creatinine clearance of >= 60 mL/min 1.73 m^2
Creatinine of less than 2.0 mg/dL, or if the patient has a serum creatinine >= 2.0, a measured creatinine clearance (Ccr) must be > 60 mL/min/1.73m^2
Creatinine < 2.0 mg/dL, or creatinine clearance > 60 mL/min
Serum creatinine of < 1.5 mg/dl and/or creatinine clearance of > 60 mL/min
Creatinine clearance >= 60 mL/min, unless secondary to renal involvement by lymphoma; for creatinine clearance < 50 mL/min due to kidney involvement by tumor
Serum creatinine clearance (CrCl) >= 30 ml/min
CrCL >= 40 ml/min
Creatinine clearance within 2 weeks of registration must be at least 60 ml/min
Creatinine < 1.5 and creatinine clearance > 45
Creatinine =< 2.0 mg/dl or creatinine clearance > 50 ml/min
Creatinine =< 1.4 mg/dL or creatinine clearance >= 50 mL/min
Creatinine =< 1.5 mg/dl or creatinine clearance >= 50 ml/min
Renal Function (creatinine clearance or serum creatinine):
Serum creatinine ? 1.5 x ULN; or a creatinine clearance ?40 mL/min;
Serum creatinine ? 2 x ULN or estimated creatinine clearance ? 50 ml/min.
Serum creatinine =< 1.5 mg/dL or creatinine clearance of >= 60 mL/min based on a 24-hour urine collection
Creatinine clearance (measured via 24-hour urine collection) >= 40 mL/minute (that is, if serum creatinine is > 1.5 x ULN, a 24-hour urine collection to calculate creatinine clearance must be performed)
Estimated creatinine clearance ? 30 mL/min.
Creatinine clearance 30 to 69 mL/min.
Estimated creatinine clearance ? 30 mL/min.
Serum creatinine ? 1.5 x ULN, or 24-hr clearance ? 60 mL/min,
Estimated Creatinine Clearance ?30 mL/min
Creatinine clearance >= 50 mL/min
(R) Renal insufficiency (serum creatinine >2 mg/dl)(177 µmol/L or more) or creatinine clearance < 40 ml/min
Parts A and C: Renal function, as follows: serum creatinine ? 2.0 mg/dL, or measured 24 hour creatinine clearance of ? 45 mL/min
Creatinine =< 2 x ULN or creatinine clearance (CrCl) > 30 ml/min
Creatinine clearance or estimated GFR . 60 mL/min/1.73m2
Serum creatinine (Cr) > 1.5 mg/dL or creatinine clearance < 50 ml/min/1.73 m^2 unless lymphoma related
Renal: Creatinine clearance ?50mL/min;
Creatinine clearance > 45 mL/min.1.73m^2 as estimated by modified Modification of Diet in Renal Disease (MDRD) equation
Serum creatinine < 2 mg/dL or creatinine clearance (CrCl) > 30 mL/min
serum creatinine clearance ?60 mL/minute
Renal function: Estimated creatinine clearance ? 45 ml/min or serum creatinine ? 2.5 mg/dL
Patients deemed to have severe renal impairment should not be considered for this study; patients with creatinine clearance (CrCl) of < 40 mL/min should be excluded
Serum creatinine < 1.5 mg/dl or creatinine clearance (CC) ? 50 ml/min
Serum creatinine =< 1.5 mg/dL OR an estimated creatinine clearance from 24 hour urine collection >= 50 ml/min
Creatinine clearance inferior to 30 mL per min (MDRD Formula).
Creatinine clearance >=50 milliliter per minutes (mL/min).
Creatinine clearance or radioisotope GFR ? 70mL/min/1.73m2 or serum creatinine based on age/gender.
Creatinine clearance >= 60 ml/minute
Serum creatinine =< 2 md/dL or estimated creatinine clearance (CrCl) > 50ml/min/body surface area (BSA)
Estimated Creatinine Clearance ?30 mL/min
Patients must have a creatinine clearance >= 30 ml/min within 28 days of registration to be eligible for the study; this will be determined by Cockroft-Gault calculation and 24-hour urine creatinine clearance measurement (please note, renal function, measured by 24-hour urine creatinine clearance in screening and post operatively, are required)
For patients who have creatinine clearance that meets > 50 ml/min they must not have received prior systemic doxorubicin
Within 14 days of study start: Serum creatinine =< 1.5 x ULN, or 24-hr clearance >= 60 ml/min; and
Creatinine clearance > 50 ml/min
Creatinine clearance >= 30 mL/min
Serum creatinine =< 1.5 x institution’s ULN or 24-hour creatinine clearance >= 50 ml/min
Serum creatinine =< 2 x ULN or 24-hour creatinine clearance >= 60 ml/min
Creatinine clearance (CrCl) >= 30 mL/min
Measured creatinine clearance > 50 ml/min or estimated creatinine clearance > 50 ml/min
Serum creatinine =< 1.5 x institution's ULN or 24-hour creatinine clearance >= 50 ml/min
Creatinine clearance >= 30 mL/min
Serum Creatinine or Creatinine Clearance** ? 1.5 x ULN, > 50 mL/min
Serum creatinine ? 1.5 × upper limit of normal (ULN) or creatinine clearance (CrCl) ? 40 mL/min/1.73 m
Serum creatinine =< 1.5 mg/dL or creatinine clearance >= 50mL/min
Creatinine clearance ? 60 cc/min
Creatinine =< 1.5 x ULN or creatinine clearance >= 60 mL/min/1.73 m^2
Serum creatinine =< 1.5 mg/dL or creatinine clearance >=50 mL/min.
Adequate biochemistry laboratory results (AST/SGOT and ALT/SGPT ? 3.0 x upper limit of normal; bilirubin ? 2.0 mg/dL; creatinine clearance of ? 40 mL/min).
Creatinine clearance (CrCL) >= 25 ml/min
Estimated creatinine clearance >= 30ml/min
Creatinine clearance >= 40 mL/min
Renal: Estimated or measured creatinine clearance >= 60 mL/min.
Creatinine =< 2 x ULN or creatinine clearance (CrCl) > 30 ml/min
Obtained within 14 weeks prior to registration on study: serum creatinine < 2.0 mg/dl and creatinine clearance > 40 mL/min
Severe chronic renal disease (serum creatinine > 2.0 mg/dl and confirmed by creatinine clearance < 40 mL/minute)
Has adequate renal function defined as serum creatinine or ? 1.5 × ULN and creatinine clearance or ? 40 ml/min.
Serum creatinine > 2 mg/dL OR creatinine clearance level (CrCL) < 30ml/min
Subject has severe renal impairment (creatinine clearance < 30 ml/min).
Creatinine clearance >= 45 mL/min
Pediatric patients must have creatinine clearance >= 60 mL/min/1.73 m^2 regardless of serum creatinine level
Obtained =< 21 days prior to registration: Estimated creatinine clearance >= 60 mL/min or a creatinine =< 2.2 mg/dL
Creatinine (Cr) clearance >= 30 mL/min
Creatinine clearance > 45 mL/min (or serum creatinine [SCr] =< 1.5 mg/dL), normal within 2 weeks prior to start of treatment
24-hour (hr) creatinine clearance >= 30 cc/min
Serum creatinine =< 1.5 x ULN or 24-hour clearance >= 50 mL/min
Calculate creatinine clearance >=40 millilitre/ minute (mL/min) (With the exception of those subjects who have Gilbert's syndrome; the bilirubin in these subjects should be at their baseline)
Creatinine clearance > 30 ml/min
Creatinine =< 1.5 mg/dL OR creatinine clearance (measured) >= 50 mL/min
Serum creatinine =< 1.5 x ULN or 24 hour creatinine (Cr) clearance > 50 ml/min
Creatinine <1.5 X upper limit of normal or estimated plasma creatinine clearance of ?40 mL/min
Creatinine =< 1.5 times ULN OR measured creatinine clearance > 60 mL/min
Creatinine clearance < 50 mL/min
Creatinine < 1.5 mg/dl or creatinine clearance > 40 ml/min
Estimated creatinine clearance (Clcr) >= 30 mL/minute
Creatinine clearance of >= 60 ml/min
Serum creatinine =< 1.5 mg/dl; creatinine (Cr) clearance should be > 50 mL/min
Within 30 days prior to initiation of protocol treatment: Creatinine serum =< 1.5 mg/dL or creatinine clearance >= 45 mL/min\r\n* If calculated creatinine clearance is < 45 mL/min, a 24-hour urine collection for creatinine clearance may be performed
Creatinine clearance >= 50 mL/min
Serum creatinine =< 1.5 x institutional ULN or 24-hour clearance >= 50 mL/min
Serum creatinine =< 2.0 mg/dl or creatinine clearance > 60 ml/min
Creatinine < 2.0 mg/dL or creatinine clearance >= 50 mL/min
Creatinine =< 2.0 mg/dL or creatinine clearance >= 50 mL/min
Serum creatinine =< 1.5 x ULN or 24-hour clearance >= 50 ml/min
Participants must not have a creatinine > 3 mg/dl or a GFR < 30 mL/min/1.73m^2
Renal function creatinine =< 2.0 mg/dL and/or creatinine clearance >= 50 ml/min
Serum creatinine =< 1.5 mg/dL and/or creatinine clearance >= 50 mL/min
Creatinine =< 1.5 mg/100 ml (or measured 24 hour creatinine clearance of >= 50 cc/min)
Renal: serum creatinine (sCr) ?2.0 x ULN, or creatinine clearance (Ccr) ?30 mL/min.
Serum creatinine =< 1.5 mg/dL (133 umol/L)\r\n* Or, if > 1.5 mg/dL: calculated creatinine clearance (ClCR) >= 30 mL/min to >= 50 mL/min
Serum creatinine < 1.6 mg/dl and/or measured creatinine clearance from 24-hour urine collection of >= 60 ml/min
Creatinine clearance ? 60mL/min
Creatinine clearance >= 45 mL/min; (creatinine < 2 mg/dL to receive cisplatin)
Creatinine < 1.8mg/mL
Serum creatinine =< 1.5 x ULN or 24-hour clearance >= 50 mL/min
Serum creatinine =< 1.5 x ULN or 24-hour clearance >= 50 ml/min
Renal: Serum creatinine (sCr) ?1.5 x upper limit of normal, or creatinine clearance (Ccr) ?50 mL/min.
Serum creatinine =< 1.2 mg/dl or if serum creatinine is outside the normal range, then creatinine clearance (CrCl) > 40 ml/min (measured or calculated/estimated) with dose adjustment for fludarabine for < 70 ml/min
Creatinine (Cr) clearance >= 60 mL/min
Normal serum creatinine or creatinine clearance >= 60 ml/min/1.73 m^2
Creatinine clearance < 30
Serum creatinine =< 1.5 x institution's ULN or 24-hour creatinine clearance >= 50 ml/min
Subjects with a determination of renal function based on: serum creatinine =< 1.5 mg/dL or if serum creatinine is outside the normal range, then creatinine clearance (CrCl) > 60-ml/min/1.73 m^2
Estimated creatinine clearance of >= 40 ml/min
Creatinine Clearance of ? 50 mL/min
Calculated creatinine clearance ? 30 mL/min NOTE: Participants with a low creatinine clearance ? 60 mL/min (or ? 50 mL/min, according to lenalidomide prescribing information/local practice) were to receive a reduced lenalidomide dose of 10 mg once daily (QD) on Days 1 through 21 of a 28-day cycle. The lenalidomide dose may have been escalated to 15 mg QD after 2 cycles if the participant was not responding to treatment and was tolerating the treatment. If renal function normalized (ie, creatinine clearance >60 mL/min or >50 mL/min, according to lenalidomide prescribing information/local practice) and the participant continued to tolerate this treatment, lenalidomide may then have been escalated to 25 mg QD.
Serum creatinine < 1.4 mg/dl or creatinine clearance >= 60 ml/min (prior to start of radiation)
Creatinine clearance: the standard Cockcroft and Gault formula must be used to calculate creatinine clearance (CrCl) for enrollment or dosing; also include in the pre-treatment or baseline text portion of the protocol, the 'On Study Evaluations or During Treatment' for every pemetrexed treatment day, and also capture in the study Schedule of Events; no dosage adjustment is needed in patients with creatinine clearance > 45 mL/min; insufficient numbers of patients have been studied with creatinine clearance < 45 mL/min to give a dose recommendation; therefore, pemetrexed should not be administered to patients whose creatinine clearance is < 45 mL/min
Serum creatinine of < 2 mg/dl or creatinine clearance of > 50 cc/min
The patient has serum creatinine <2×ULN and not rising for at least 2-4 weeks before chemotherapy. If elevated, the 24-hour creatinine clearance must be >50 mL/min
Creatinine clearance >= 50 mL/min
Creatinine clearance (CrCl) > 50 mL/min
Creatinine =< 2.0 mg/dL or creatinine clearance >= 50 mL/min
Serum creatinine =< 1.5 mg/dl OR creatinine clearance >= 30 ml/min (as estimated by Cockroft Gault equation)
creatinine clearance of < 30 mL/min
Creatinine < 1.5 mg/dL; if question about renal function discuss with study chairman and do 24 hour creatinine clearance (clearance should be > 50 ml/min)
Creatinine within normal institutional limits OR creatinine clearance >= 50 mL/min/1.73 m^2 for patients with serum creatinine < 2 mg/mL
Serum creatinine of ?1.5 × the upper limit of normal (ULN)OR estimated creatinine clearance (CrCl) ? 40 ml/min/1.73 m2
Creatinine =< 2.0 mg/100 ml
Adequate renal function defined by measured creatinine clearance >= 50 mL/min by a 24-hour urine collection
Creatinine clearance of > 60 ml/min
Serum creatinine =< 1.5 mg/dL or creatinine clearance >= 50 mL/min based on a 24-hour urine collection
Estimated creatinine clearance < 50 ml/min
Renal insufficiency of creatinine clearance <40mL/min
Must have adequate organ function as defined by the following baseline values: Absolute neutrophil count (ANC) >/=1.5x10^9/L Hemoglobin >/=9 g/dL Platelets >/=100x10^9/L Prothrombin time /International normalized ratio (INR) and partial thromboplastin time </=1.5xULN (Subjects receiving anticoagulation treatment may be allowed to participate with INR established within the therapeutic range prior to starting study treatment.) Total bilirubin </=1.5 x upper limit of normal (ULN) Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) </= 2.5xULN Serum creatinine </=1.5 mg/dL (if serum creatinine is >1.5 mg/dL, calculate creatinine clearance using standard Cockcroft and Gault; creatinine clearance must be > 50 mL/min); creatinine clearance should be >/= 50 mL/min Left ventricular ejection fraction >/= institutional lower limit of normal ECHO
Serum creatinine =< 1.5 X ULN OR 24-hour creatinine clearance >= 60 mL/min
Patients must have an estimated creatinine clearance greater than 50/ml per minute (serum creatinine value must be within 28 days prior to registration)
Serum creatinine =< 1.5 mg/dl and a creatinine clearance >= 30 ml/min
Creatinine clearance estimated to be >= 30 ml/min
Previous inability to tolerate full-dose lenalidomide, adjusted to creatinine clearance (CrCl) according to Cockroft-Gault at the time of previous lenalidomide treatment (25 mg day 1-21 every 28 days if CrCl >= 60 ml/min, 10 mg lenalidomide days (d) 1-21 every 28 days if CrCl < 60 mL/min but >= 30 mL/min, lenalidomide 15 mg every 48 hours (h) d1-21 every 28 days if CrCl < 30 mL/min but not requiring dialysis, lenalidomide 5 mg daily, day 1-21 every 28 days if CrCl < 30 mL/min and requiring dialysis
Serum creatinine < 2.5 mg/dL or creatinine clearance > 40ml/min
Renal: serum creatinine =< 1.2 mg/dl or if serum creatinine is outside the normal range, then creatinine clearance (CrCl) > 40 ml/min (measured or calculated/estimated) with dose adjustment of fludarabine for < 70 ml/min
Serum creatinine ? 1.5 × ULN according to institutional standards or creatinine clearance ? 50 mL/min
Creatinine clearance (CrCl) < 30mL/min
Inadequate renal function defined as measured creatinine clearance less than 50 mL/min/1.73 m^2 based on the Cockcroft-Gault formula (adults) or Schwartz formula (age less than or equal to 12 years). Adults: estimated creatinine clearance rate (eCCr) (mL/min/) = (140 - age) x mass (kg) x (0.85 if female)/72 x serum creatinine (mg/dL; Creatinine clearance (mL/min/1.73m^2) = eCCr x 1.73/Body Surface Area (BSA) (m^2); Children: eCCr (mL/min/1.73 m^2) = k x height (cm) / serum creatinine (mg/dL) k = 0.33 (pre-term), 0.45 (full term to 1 year old), 0.55 (age 1-12 years).
Estimated creatinine clearance (CCL) > 60 cc/min
Creatinine < 2.0 mg/100 ml
Creatinine =< 1.5 mg/dL or creatinine clearance >= 60 ml/min
Creatinine clearance < 40 ml/min
Either serum creatinine =< 1.5 mg/dL or measured creatinine clearance >= 60 mL/min
Estimated creatinine clearance >= 60 mL/min or a creatinine =< 2.2 mg/dL obtained =< 14 days prior to registration
Serum creatinine < 1.6 mg/dL or creatinine clearance >= 50 ml/min
Serum creatinine =< 2.0 x upper limit of normal (ULN) or serum creatinine clearance (CrCl) >= 40 ml/min (drug is not cleared by the kidney)
Patients must have a creatinine clearance greater than 50/ml per minute by the following formula (test must be performed within 28 days prior to registration):\r\n* Creatinine clearance (CrCl) = (140-age) (Wt in Kg) x 0.85 (female) OR 1.0 (male)/72 x serum Cr
Creatinine =< 1.5 mg/dl and creatinine clearance >= 50 ml/min/1.73 m^2
Serum creatinine =< 2 x the institutional ULN and measured or estimated creatinine clearance >= 50 cc/min
Patients must have either (a) normal kidney function (i.e. creatinine =< 1.5 X upper limit of normal [ULN] OR calculated creatinine clearance >= 60 mL/min by the modified Cockcroft and Gault Formula OR a creatinine clearance >= 60 mL/min obtained from a 24-hour urine collection) or (b) moderate or severe renal dysfunction (i.e. creatinine clearance < 60 mL/min and >= 20 mL/min)
Serum creatinine =< 1.5 mg/dl or creatinine clearance > 50 ml/min
Patients with a creatinine clearance < 60 ml/min/1.73 m^2 body surface area
Creatinine clearance (Clcr) > 25 mL/min
Creatinine clearance >= 40 ml/min
Serum creatinine < 1.5 mg/dL or creatinine clearance greater than or equal to 40 cc/min as defined by Modification of Diet in Renal Disease (MDRD) method from National Kidney Disease Education Program (NKDEP)
creatinine clearance < 70 mL/min, or
Estimated creatinine clearance (CLcr) > 25 ml/min
Creatinine (Cr) < 1.5 mg/dL or creatinine clearance > 50 mL/min/m^2
Creatinine clearance of >= 60 ml/min
Creatinine =< 2.0 X ULN OR creatinine clearance >= 30 mL/min/1.73 m^2
Creatinine clearance >= 60 ml/mm
Serum creatinine (Cr) =< 2 x ULN or 24-hour creatinine clearance >= 50 ml/min
Adequate renal function, defined as serum creatinine ? 2.0 times ULN and creatinine clearance > 50 mL/min
Renal clearance CCR < 40 mL/min
Renal: serum creatinine (sCr) ?2.0 x ULN, or creatinine clearance (Ccr) ?30 mL/min.
Renal: Serum creatinine within normal range for age, or if serum creatinine outside normal range for age, then renal function (creatinine clearance or GFR) > 70mL/min/1.73m2.
Renal function\r\n* ARM A: Creatinine clearance > 60 ml/min\r\n* ARM B: No limitation
Renal function: Age-adjusted normal serum creatinine is required. A 24-hour creatinine clearance value > 60 mL/min/1.73 m2 (updated Schwartz formula or nuclear GFR) must be obtained if serum creatinine is elevated.
Serum creatinine =< 1.5 x ULN or 24-hour clearance >= 50 mL/min
Creatinine clearance >= 30 ml/min
Creatinine clearance > 30 mL/min
Serum creatinine =< 2.0 mg/dl or creatinine clearance >= 60 mL/min
Serum creatinine < 2 x ULN or creatinine clearance > 60 mL/min
Serum creatinine =< 1.5 X ULN and stable X 1 month OR creatinine clearance >= 60 Ml/min/1.73 m^2
Serum creatinine < 1.5 x ULN or creatinine clearance ? 60 mL/min as measured by institutional standards
Serum creatinine =< 1.5 mg/dl and/or creatinine clearance >= 50 mL/min
Creatinine clearance >= 30 mL/min
Creatinine < 1.8 mg/dl (or creatinine clearance > 40 ml/min)
Serum creatinine >1.5 x ULN or creatinine clearance ? 45 mL/min
Serum creatinine =< 1.5 x ULN or creatinine clearance >= 50 mL/min
Creatinine =< 1.5 mg/dL to receive weekly intravenous cisplatin*; *patients whose serum creatinine is between 1.5 and 1.9 mg/dL are eligible for cisplatin if the estimated creatinine clearance is >= 30 ml/min; for the purpose of estimating the creatinine clearance, the formula of Cockcroft and Gault for females should be used
Creatinine Clearance ? 50 ml/min
Creatinine clearance < 30 ml/min which cannot be attributed to MCC metastasis
Patients with creatinine clearance: < 50 mL/min are excluded from this protocol; capecitabine is contraindicated in severe renal impairment (clearance < 40 mL/min)
Creatinine clearance ? 30 mL/min
Creatinine clearance > 50 ml/min
Serum creatinine < 1.5 x upper limit of normal (ULN) or serum creatinine clearance (CrCl)> 40ml/min (CrCl= Wt (kg) x (140-age)*/72 x Cr. level, *female x 0.85)
Adequate renal function (creatinine clearance greater than equal to (?) 45 milliliters per minute [mL/min])
Creatinine clearance must be > 60ml/min
Creatinine clearance >= 30 mL/minute
TREATMENT: Serum creatinine less than or equal to 1.6 mg/ml or the creatinine clearance must be greater than 70 ml/min/1.73 m^2
Creatinine clearance >= 40mL/min
Renal impairment at baseline as measured by serum creatinine clearance (CrCl) ?60 mL/min ?21 days prior to registration.
Patient must have adequate renal function as defined by a calculated creatinine clearance of >30 mL/min per 1.73 m[2] determined using the Schwartz equation: Creatinine clearance (ml/min per1.73 m[2]= (height [cm] x k)/ (serum creatinine [mg/dL]) where k is a standard proportionality constant based on patient's gestational age, chronologic age and gender.
Serum creatinine =<1.5 mg/dl OR creatinine clearance >= 30 ml/min (as estimated by Cockroft Gault equation)
Creatinine clearance >= 50 ml/min
Serum creatinine =< 1.5 x ULN, or 24-hour (hr) clearance >= 60 ml/min
Creatinine clearance > 25 mL/min or creatinine =< 1.5 mg/dL
Severe renal impairment (creatinine clearance =< 30 ml/min)
Serum creatinine =< 1.5 x ULN or creatinine clearance >= 50 mL/min
A measured or estimated creatinine clearance (CrCl) ?60 mL/min/1.73 m2
Creatinine ?2.0 x ULN or Creatinine Clearance ?40 mL/min
Creatinine =< 1.5 mg/dL or creatinine clearance > 60 ml/min
Creatinine (Cr) clearance > 50 mL/min by Modification of Diet in Renal Disease (MDRD) calculation
Adequate renal function as evidenced by: serum creatinine ?2.0 × ULN; OR creatinine clearance > 40 mL/min based on the Cockroft-Gault GFR estimation: (140 - Age) x (weight in kg) x (0.85 if female)/72 x serum creatinine
Creatinine clearance ? 50 mL/min
Serum creatinine =< 1.5 x upper limit of normal OR creatinine clearance on a 24-h urine collection of >= 50 mL/min
Creatinine clearance of 50 or greater
Patients with a creatinine clearance of less than 50 are ineligible
Creatinine < 2.0 x upper limit of normal and/or a creatinine clearance >= 60 ml/min
Creatinine clearance > 40
Serum creatinine =< 1.5 x ULN (or 24-hour creatinine clearance >= 50 ml/min)
Serum creatinine =< 1.5 x ULN and creatinine clearance > 30 ml/min
DONOR: Creatinine clearance > 80 ml/minute as measured from a 24 hour urine collection within 26 weeks of the screening visit; if a serum creatinine drawn at the screening visit is > 20% higher than the serum creatinine drawn at the time of the 24 hour urine collection, the creatinine clearance must be re-evaluated by a repeat 24 hour urine test; if the new value is =< 80 mg/dL the donor will be excluded
Estimated serum creatinine clearance >= 50 ml/min (Modification of Diet in Renal Disease [MDRD] method from National Kidney Disease Education Program, [NKDEP]) and/or serum creatinine =< 1.8 mg/dL
Serum creatinine <=1.5 mg/dL (If serum creatinine is >1.5 mg/dL, calculate creatinine clearance using standard Cockcroft and Gault Method Creatinine clearance must be >50 mL/min)
Creatinine clearance > 40 ml/min
Adequate renal function as demonstrated by serum creatinine ? 1.5 x ULN, or 24-hr urine creatinine clearance calculation >60 mL/min
Serum creatinine =< 1.5 mg/dl or measured creatinine clearance of > 30 ml/min
Serum Creatinine ? 1.5 x ULN, or Creatinine Clearance > 45mL/min
Creatinine clearance >= 50 cc/min
Serum creatinine less than 1.6 mg/dl and creatinine clearance >= to 30 mL/min
Estimated creatinine clearance of ?40 mL/min
Creatinine clearance >= 50 mL/min
Adequate renal function (serum creatinine =< 2.0 mg/dL or creatinine clearance >= 50 ml/min)
Either creatinine > 2.0 mg/dL or creatinine clearance < 30 mL/min
Serum creatinine =< 2.0 mg/dl OR creatinine clearance >= 60 mL/min/1.73 m^2 for patients with creatinine levels above 2.0
creatinine <2.0 mg/dL OR creatinine clearance >50 mL/min/1.73 m2
Serum creatinine =< 1.5 x ULN or 24-hour clearance >= 50 mL/min
Measured creatinine clearance >= 60 mL/min
Serum creatinine ?2 mg/dL or creatinine clearance > 60 mL/minute;
Chronic or acute renal insufficiency as defined by a preoperative serum creatinine greater than 1.5mg/dL or creatinine clearance of < 60 ml/min
Serum creatinine =< 1.5 mg/dL or creatinine clearance >= 60 mL/min based on 24-hour urine collection
Creatinine clearance >= 40 mL/min
Serum creatinine =< 1.5 x ULN or 24-hour creatinine clearance >= 50 ml/min
Donor must have adequate renal function as defined by a minimum creatinine clearance (CrCl) value of >30 ml/min.
Severe renal impairment: estimated creatinine clearance (CrCl) <30 ml/min, but not requiring dialysis
Adequate renal function, defined as Creatinine Clearance >60 mL/min or serum creatinine of ? 1.3 mg/dL (115 ?M).
Creatinine Clearance < 45 mL/min
Serum creatinine =< 1.5 X ULN or 24-hour clearance >= 55 mL/min
Renal function: Serum creatinine ? 1.5 x ULN or 24-hour clearance ? 40 ml/min, Serum potassium, magnesium and calcium must be within normal limits
Subjects with creatinine clearance ?10 mL/min who are not being treated with continuous renal replacement therapy (CRRT).
Patients must have a serum creatinine within normal limits, or an estimated or measured creatinine clearance >= 65 ml/min
Creatinine clearance (CrCl) ? 50 mL/minute within 21 days prior to randomization
Total Cumulative Illness Rating Scale (CIRS) > 6 and/or creatinine clearance < 70 ml/min
Estimated serum creatinine clearance > 60 ml/min
Creatinine clearance >= 40 ml/min; creatinine clearance will be determined by testing of a 24 hour urine collection and simultaneous serum creatinine value
Creatinine clearance > 60 mL/min/1.73 m^2 or normal age adjusted serum creatinine (=< 5 years [yrs.] =< 0.8 mg/ml; 5-10 yrs. =< 1.0 mg/ml; 10-15 yrs. =< 1.2 mg/ml; > 15 yrs. =< 1.5 mg/ml)
Creatinine clearance > 60 mL/min/1.72 m^2 or normal age adjusted serum creatinine (=< 5 yrs. =< 0.8 mg/ml; 5-10 yrs. =< 1.0 mg/ml; 10-15 yrs. =< 1.2 mg/ml; > 15 yrs. =< 1.5 mg/ml)
Creatinine clearance > 60 mL/min/1.73 m^2 or normal age adjusted serum creatinine (=< 5 yrs. =< 0.8 mg/ml; 5-10 yrs. =< 1.0 mg/ml; 10-15 yrs. =< 1.2 mg/ml; > 15 yrs. =< 1.5 mg/ml)
Creatinine =< 1.5 mg/dl and/or creatinine clearance >= 60 mL/min/1.73 m^2
Serum creatinine of <=2.0 mg/dL or creatinine clearance >=50 mL/min
Creatinine clearance of > 40 ml/min/1.73m^2
Serum creatinine =< 1.5 x ULN or creatinine clearance (CrCl) >= 40 mL/min
Creatinine =< 3 mg/dL and creatinine clearance (CrCL) >= 25 ml/min
Estimated serum creatinine clearance >= 50 ml/min and/or serum creatinine =< 1.8 mg/dL
Creatinine clearance >= 25 mL/min
Serum creatinine less than or equal to 1.6 mg/ml or the creatinine clearance must be greater than 70 ml/min/1.73m^2
Creatinine clearance >= 30 mL/min
Must have a serum creatinine < 2.0 and creatinine clearance > 30 ml/min/m^2; other organ dysfunction is eligible at the discretion of the Principal Investigator (PI)
Serum creatinine =< 3 mg/dL and creatinine clearance >= 30 ml/min
Patients with a creatinine clearance of < 60 ml/min
Renal: creatinine clearance >=60 milliliter per minute (mL/min).
CrCL ? 40 mL/min
Patients with severe renal insufficiency, defined and confirmed by an estimated creatinine clearance equal or lower than 30 mL/min, per institutional laboratory.
Patients with severe renal impairment defined as creatinine clearance of 15-29 mL/min and/or diagnosed with stage 4 chronic kidney disease
Creatinine > 1.5 x ULN or creatinine clearance levels (CrCL) < 45 mL/min
Moderate to severe renal failure (creatinine clearance [Clcr] < 30 mL/min)
Patients with a creatinine clearance < 30 mL/min
Acute or chronic renal insufficiency with creatinine clearance < 30 mL/min, drawn within 28 days of consent
Measured creatinine clearance more than 60 mL/min; the updated Schwartz formula should be used for pediatric patients (>= 5 to 12 years old)
Serum creatinine =< 3 mg/dL (265 umol/L) and creatinine clearance >= 30 ml/min
Chronic kidney disease or in participants without known kidney disease, estimated creatinine clearance of =< 30 ml/min, even after rehydration
Maximum serum creatinine of 1.5 mg/dL OR a creatinine clearance >= 70 ml/min/1.73m^2
Creatinine clearance >= 50 ml/min
Estimated creatinine clearance ? 50ml/min
Creatinine clearance >= 30 mL/min
Creatinine =< 1.5 mg/dl and/or creatinine clearance >= 60 mL/min
Estimated creatinine clearance (CrCl) >= 30 ml/min
Estimated creatinine clearance >= 30 ml/min
Creatinine clearance (CrCl) < 30 ml/min
Patients with creatinine clearance of less than or equal to 50 ml/min
Creatinine clearance ? 30 mL/min
A serum creatinine of equal or less than 2.0mg/dl or a creatinine clearance of 50 mL/min or greater on 24 hour urine collection
Creatinine value of =< 1.5 x upper limit of normal (ULN) or creatinine clearance value of >= 40 mL/min
Patients must have creatinine of less than or equal to 1.5 mg/dL or creatinine clearance > 60 ml/min
Creatinine =< 1.5, or creatinine clearance >= 45 mL/min
known renal insufficiency with estimated creatinine clearance (eGRF) of less than 54 mL/min;
Serum creatinine =< 2.0 mg/dl or creatinine clearance > 60 ml/min within 90 days of enrollment
Creatinine < 1.5 mg/dL or estimated creatinine clearance >= 50 mL/min/1.73 m^2
Measured creatinine clearance more than 60 mL/min; the updated Schwartz formula should be used for pediatric patients (>= 5 to 12 years old)
Estimated creatinine clearance >= 50 cc/min
Creatinine clearance >= 50 cc/min
Serum creatinine (CR) < 1.5mg/dl or 24 hour CR clearance < 50 ml/min
Estimated creatinine clearance >= 60 ml/min
Significant renal disease as defined by creatinine clearance less than 30 mL/min
Creatinine clearance or radioisotope GFR >= 60 ml/min/1.73 m^2
Creatinine clearance >= 50 cc/min
Creatinine clearance >= 30 mL/min
Hypocalcemia (serum calcium or albumin adjusted calcium < 8.0 mg/dL) or renal dysfunction (creatinine clearance < 30 mL/min)
Individuals if creatinine clearance is < 50
Creatinine clearance (CrCl) >= 30 milliliter per minute (mL/min)
Estimated serum creatinine clearance of ? 50 mL/min
Age-adjusted normal serum creatinine or a creatinine clearance ? 40 ml/min
Renal insufficiency, preferably determined by creatinine clearance less than (<)40 milliliter per minute (mL/min) measured or estimated using the Modification of Diet in Renal Disease (MDRD), or serum creatinine >177 micromole per liter (?mol/L)
Serum creatinine < 1.5 mg/dL or creatinine clearance >= 50 mL/min
Patients with impaired renal function creatinine clearance (CRCL) =< 60 mL/min
Within 14 days prior to study entry: Serum creatinine < 1.5 mg/dl OR creatinine clearance of >= 50 cc/min
Serum creatinine (serum or plasma) ? 1.5 x ULN or GFR>50 mL/min
Creatinine > 1.5 x ULN or creatinine clearance < 60 mL/min from assays obtained < 2 weeks prior to study enrollment
Patients with a creatinine clearance less than 60
Creatinine > 1.5 x ULN or creatinine clearance < 60 mL/min, from assays obtained < 2 weeks prior to study enrollment
Creatinine >1.5 x ULN or creatinine clearance < 60 mL/min
Creatinine > 1.5 x ULN or creatinine clearance < 60 mL/min
Creatinine > 1.5 x ULN or creatinine clearance < 60 mL/min, from assays obtained < 2 weeks prior to study enrollment
Severe renal impairment (i.e. creatinine clearance < 40 mL/min)
Creatinine =< 2 x ULN or creatinine clearance (CrCl) > 30 ml/min
Creatinine =< 1.5 x ULN or creatinine clearance >= 50 mL/min using 24- hour urine collection for creatinine clearance, completed within 2 weeks prior to start of protocol therapy
Chronic or acute renal insufficiency as defined by a preoperative serum creatinine greater than 1.5 mg/dL or creatinine clearance of < 40 ml/min
Serum creatinine =< 1.3 mg/dL and creatinine clearance > 50 mL/min
serum creatinine ?1.8 mg/dL or creatinine clearance > 50 mL/min (Appendix I);
Estimated creatinine clearance < 50 mL/min
Serum creatinine >2.0 x ULN, or estimated creatinine clearance <40mL/min
